Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Sci Rep. 2023 Nov 10;13(1):19652. doi: 10.1038/s41598-023-46524-y.
To investigate the value of T technique on 3.0 T magnetic resonance imaging (MRI) in evaluating the changes of cardiac and hepatic iron load before and after hematopoietic stem cell transplantation (HSCT) in patients with thalassemia (TM), the 141 TM patients were divided into 6 group for subgroup analysis: 6, 12, 18, 24 and > 24 months group, according to the postoperative interval. The T values of heart and liver (H-T, L-T) were quantified in TM patients before and after HSCT using 3.0 T MRI T technology, and the corresponding serum ferritin (SF) was collected at the same time, and the changes of the three before and after HSCT were compared. The overall H-T (P = 0.001) and L-T (P = 0.041) of patients after HSCT were higher than those before HSCT (mean relative changes = 19.63%, 7.19%). The H-T (P < 0.001) and L-T (P < 0.001) > 24 months after HSCT were significantly higher than those before HSCT (mean relative changes = 69.19%, 93.73%). The SF of 6 months (P < 0.001), 12 months (P = 0.008), 18 months (P = 0.002) and > 24 months (P = 0.001) were significantly higher than those before HSCT (mean relative changes = 57.93%, 73.84%, 128.51%, 85.47%). There was no significant improvement in cardiac and liver iron content in TM patients within 24 months after HSCT, while the reduction of cardiac and liver iron content in patients is obvious when > 24 months after HSCT.
为了探讨 3.0T 磁共振成像(MRI)T 技术在评估地中海贫血(TM)患者造血干细胞移植(HSCT)前后心脏和肝脏铁负荷变化中的价值,将 141 例 TM 患者根据术后间隔分为 6 组进行亚组分析:6、12、18、24 和>24 个月组。采用 3.0T MRI T 技术对 TM 患者 HSCT 前后心脏和肝脏的 T 值(H-T、L-T)进行定量,并同时采集相应的血清铁蛋白(SF),比较 HSCT 前后三者的变化。HSCT 后患者的整体 H-T(P=0.001)和 L-T(P=0.041)均高于 HSCT 前(平均相对变化率分别为 19.63%和 7.19%)。HSCT 后>24 个月的 H-T(P<0.001)和 L-T(P<0.001)均明显高于 HSCT 前(平均相对变化率分别为 69.19%和 93.73%)。6 个月(P<0.001)、12 个月(P=0.008)、18 个月(P=0.002)和>24 个月(P=0.001)的 SF 明显高于 HSCT 前(平均相对变化率分别为 57.93%、73.84%、128.51%和 85.47%)。HSCT 后 24 个月内 TM 患者心脏和肝脏铁含量无明显改善,而>24 个月后患者心脏和肝脏铁含量明显减少。